| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 81901 |
cas:367927-39-7,SMPH Crosslinker,琥珀酰亚胺基6-[(3-马来酰亚胺基)丙酰胺基]-己酸酯 |
138 |
kx |
2024-12-20 |
| 81902 |
cas:870487-08-4,Boc-Val-Cit |
135 |
zyl |
2024-12-20 |
| 81903 |
alpha-GalNAc-TEG-Alkyne,丙-2-炔氧基乙氧基)乙氧基)乙氧基)-2-乙酰氨基-2脱氧-α-D-吡喃半乳糖苷 |
195 |
wyh |
2024-12-20 |
| 81904 |
cas:99208-90-9,Alkynyl Palmitic Acid,15-十六碳炔酸 |
120 |
kx |
2024-12-20 |
| 81905 |
Mal-amido-PEG8-Val-Gly-PAB-OH(CAS号:2353409-52-4) |
125 |
WYQ |
2024-12-20 |
| 81906 |
MC-Gly-Gly-Phe-Gly 一种可降解 (cleavable) 的 ADC linker |
209 |
zyl |
2024-12-20 |
| 81907 |
Azido-PEG10-CH2COOH |
104 |
wyh |
2024-12-20 |
| 81908 |
Mal-amido-PEG8-Val-Gly(CAS号:2353409-54-6) |
98 |
WYQ |
2024-12-20 |
| 81909 |
Alloc-Val-Ala-PAB-PNP(CAS号:1884578-27-1) |
133 |
WYQ |
2024-12-20 |
| 81910 |
Sulfhydryl Reactive Liposomes,巯基反应脂质体 |
135 |
axc |
2024-12-20 |
| 81911 |
cas:100462-73-5,diethyl 7-bromoheptylphosphonate,7-溴庚基二膦酸二乙酯 |
126 |
kx |
2024-12-20 |
| 81912 |
Propargyl-PEG2-CH2COOH,丙炔基-二聚乙二醇-乙酸 |
127 |
wyh |
2024-12-20 |
| 81913 |
Mal-amido-PEG8-val-gly-PAB-OH - CAS 2353409-52-4 |
118 |
zyl |
2024-12-20 |
| 81914 |
DBCO-PEG4-Val-Ala-PAB-PNP,CAS号:2348405-93-4 |
132 |
WYQ |
2024-12-20 |
| 81915 |
Metal Chelating Liposomes,金属螯合脂质体 |
139 |
axc |
2024-12-20 |
| 81916 |
HS-PEG10-CH2CH2COOH,硫基十聚乙二醇丙酸 |
284 |
wyh |
2024-12-20 |
| 81917 |
cas:1446282-24-1,[10-(Diethoxy-phosphoryl)-decyl]-phosphonic acid,抗体药物偶联物(ADC) |
192 |
kx |
2024-12-20 |
| 81918 |
Folate Liposomes,叶酸脂质体 |
177 |
axc |
2024-12-20 |
| 81919 |
MC-Val-Cit-Doxorubicin ,CAS号:159857-70-2 |
130 |
WYQ |
2024-12-20 |
| 81920 |
alpha-GalNAc-TEG-Alkyne,丙-2-炔氧基乙氧基)乙氧基)乙氧基)-2-乙酰氨基-2脱氧-α-D-吡喃半乳糖苷 |
180 |
wyh |
2024-12-20 |
| 81921 |
Azido-PEG4-Val-Ala-PAB的结构式 |
174 |
zyl |
2024-12-20 |
| 81922 |
cas:5943-17-9,Tetraethyl heptane-1,7-diylbis(phosphonate), ADC试剂 |
111 |
kx |
2024-12-20 |
| 81923 |
Fmoc-PEG2-Val-Cit-PAB-OH |
158 |
zyl |
2024-12-20 |
| 81924 |
TCO-PEG3-CH2-aldehyde,环辛烯-三聚乙二醇-CH2-醛基 |
128 |
wyh |
2024-12-20 |
| 81925 |
cas:59156-70-6,Di(N-succinimidyl)adipate,己二酸 1,6-二(2,5-二氧代-1-吡咯烷基)酯 |
122 |
kx |
2024-12-20 |
| 81926 |
Boc-Val-Cit-PAB-PNP cas:870487-10-8 |
126 |
zyl |
2024-12-20 |
| 81927 |
Endo-BCN-PEG4-Val-Cit-PAB-MMAF详细信息 |
129 |
WYQ |
2024-12-20 |
| 81928 |
FMOC-N-甲基-三聚乙二醇-丙酸,Fmoc-N-methyl-PEG3-CH2CH2COOH |
133 |
wyh |
2024-12-20 |
| 81929 |
cas:98627-69-1,1,3-Bis-aminooxy propane,1,3-双氨基氧基丙烷 |
110 |
kx |
2024-12-20 |
| 81930 |
m-PEG7-CH2CH2COOH,1093647-41-6 |
132 |
wyh |
2024-12-20 |
| 81931 |
NHS ester-PEG4-VC-PAB-PBD |
114 |
zyl |
2024-12-20 |
| 81932 |
cas:894096-02-7,β-D-triacetylglucopyranosiduronyl methyl ester-phenol-β-Alanine, ADC试剂 |
129 |
kx |
2024-12-20 |
| 81933 |
Alloc-Val-Ala-PAB(CAS号:1343407-91-9) |
104 |
WYQ |
2024-12-20 |
| 81934 |
VH032-NH-CO-CH2-NHBoc,2010986-19-1 |
114 |
wyh |
2024-12-20 |
| 81935 |
Alloc-Val-Ala-OH(CAS号:330970-70-2) |
167 |
WYQ |
2024-12-20 |
| 81936 |
DBCO Reactive Liposomes,DBCO反应性脂质体 |
108 |
axc |
2024-12-20 |
| 81937 |
1714123-51-9,Tetrazine-biotin,生物素标记四嗪 |
94 |
kx |
2024-12-20 |
| 81938 |
MC-Val-Ala-OH(CAS号:1895916-22-9) |
158 |
WYQ |
2024-12-20 |
| 81939 |
Carboxylic Acid Reactive Liposomes,羧酸反应性脂质体 |
111 |
axc |
2024-12-20 |
| 81940 |
Tetrazine-C5-NHS, 四嗪-C5-N-羟基琥珀酰亚胺酯,抗体药物偶联物(ADC) |
156 |
kx |
2024-12-20 |
| 81941 |
Mal-PEG8-Val-Cit-PAB-MMAE(CAS号:2353409-69-3) |
127 |
WYQ |
2024-12-20 |
| 81942 |
Biotinylated Liposomes 生物素化脂质体 |
133 |
axc |
2024-12-20 |
| 81943 |
Endo-BCN-PEG4-Val-Cit-PAB-MMAE(CAS号:2762519-08-2) |
124 |
WYQ |
2024-12-20 |
| 81944 |
MC-VC-PAB-DMAE-Etoposide的介绍 |
110 |
zyl |
2024-12-20 |
| 81945 |
DBCO-PEG4-Val-Cit-PAB-MMAE(CAS号:2129164-91-4) |
115 |
WYQ |
2024-12-20 |